[Left ventricular end-systolic wall stress during antihypertensive treatment]

J Bulas1, J Murín, I Janiga

  • 1I. interná klinika Lekárskej fakulty UK a UN Bratislava, Slovenská republika. jozef.bulas@sm.unb.sk

Vnitrni Lekarstvi
|April 19, 2011
PubMed

Insights

Lowering blood pressure in hypertensive patients significantly reduces left ventricular systolic wall stress. Echocardiography effectively monitors this improvement, integrating heart geometry and blood pressure for evaluating antihypertensive therapy effectiveness.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Hypertension Research

Context:

  • Left ventricular hypertrophy in hypertension is a compensatory mechanism to manage increased hemodynamic load.
  • Circumferential systolic wall stress quantifies the mechanical load on the left ventricle during systole.
  • Noninvasive echocardiography and blood pressure measurements are key for assessing cardiac mechanics.

Purpose:

  • To evaluate the impact of achieving target blood pressure levels on left ventricular mean circumferential systolic wall stress in hypertensive patients.
  • To assess the role of echocardiography and systolic wall stress calculation in monitoring antihypertensive therapy effectiveness.

Summary:

  • A study of 25 female patients with treated hypertension demonstrated a statistically significant decrease in left ventricular systolic wall stress after achieving target blood pressure (<140/90 mm Hg).
  • This reduction was primarily driven by lower blood pressure and secondarily by a decrease in left ventricular end-diastolic diameter.
  • Multiple regression analysis indicated that favorable geometric remodeling, including diminished diastolic diameter and increased relative wall thickness, also contributed to the significant lowering of systolic wall stress.

Impact:

  • Systolic wall stress calculation, integrating ventricular geometry and blood pressure, is a valuable parameter for long-term antihypertensive therapy evaluation.
  • This approach offers a comprehensive, noninvasive method to monitor cardiac adaptation to blood pressure management in hypertension.
  • Findings support the use of serial echocardiographic assessments to guide and validate antihypertensive treatment strategies.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...